Bukit Uluwatu Villa Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bukit Uluwatu Villa Tbk trades at Rp725 (market cap 18.59T, 72.39M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Bukit Uluwatu Villa Tbk is far larger — about 58.8× Diagnos Laboratorium Utama Tbk.'s market cap, and Bukit Uluwatu Villa Tbk is more actively traded (72.39M versus 41.7K). Which is the better fit depends on your goals.
| BUVA | DGNS | |
|---|---|---|
Market Cap | 18.59T | 316.25B |
Volume | 72.39M | 41.7K |
Lot | 723.87K | 417 |
Turnover | 53.33B | 9.66M |
Average Price | 736.69 | 231.65 |
Value | 53.33B | 9.66M |
Indicative Equilibrium Price | 725 | 230 |
Indicative Equilibrium Volume | 12.22K | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bukit Uluwatu Villa Tbk (the “Company”) was established in the Republic of Indonesia on December 15, 2000 based on the Notarial Deed No. 53 of Sugito Tedjamulja, S.H.. The Company’s status has been changed from foreign investment company (PMA) to domestic investment company (PMDN).
Read more on BUVA →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →